CRBP2 Fundamental Analysis - CRCAM BRIE PIC2-CCI

Fundamental Rating

Overall CRBP2 gets a fundamental rating of 2 out of 10. We evaluated CRBP2 against 108 industry peers in the Banks industry. Both the profitability and financial health of CRBP2 have multiple concerns. CRBP2 does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CRBP2 was profitable.

In the past year CRBP2 has reported a negative cash flow from operations.

Each year in the past 5 years CRBP2 has been profitable.

The reported operating cash flow has been mixed in the past 5 years: CRBP2 reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of 0.53%, CRBP2 is doing worse than 63.89% of the companies in the same industry.

Looking at the Return On Equity, with a value of 3.86%, CRBP2 is doing worse than 77.78% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	0.53%
ROE	3.86%
ROIC	N/A

ROA(3y)0.47%

ROA(5y)0.46%

ROE(3y)3.92%

ROE(5y)3.92%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin of CRBP2 (26.10%) is better than 65.74% of its industry peers.

CRBP2's Profit Margin has declined in the last couple of years.

The Operating Margin and Gross Margin are not available for CRBP2 so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	26.1%
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-6.32%

PM growth 5Y-2.49%

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CRBP2 does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, CRBP2 has less shares outstanding

The number of shares outstanding for CRBP2 has been increased compared to 5 years ago.

Compared to 1 year ago, CRBP2 has an improved debt to assets ratio.

2.2 Solvency

A Debt/Equity ratio of 0.20 indicates that CRBP2 is not too dependend on debt financing.

The Debt to Equity ratio of CRBP2 (0.20) is better than 89.81% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.2
Debt/FCF	N/A
Altman-Z	N/A

ROIC/WACCN/A

WACC6.12%

2.3 Liquidity

		Industry Rank	Sector Rank
Current Ratio	N/A
Quick Ratio	N/A

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CRBP2 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.82%.

CRBP2 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.97% yearly.

The Revenue has decreased by -1.48% in the past year.

Measured over the past years, CRBP2 shows a small growth in Revenue. The Revenue has been growing by 4.72% on average per year.

EPS 1Y (TTM)7.82%

EPS 3Y-3.01%

EPS 5Y1.97%

EPS Q2Q%14.31%

Revenue 1Y (TTM)-1.48%

Revenue growth 3Y3.81%

Revenue growth 5Y4.72%

Sales Q2Q%-1.45%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 7.02, which indicates a rather cheap valuation of CRBP2.

Compared to the rest of the industry, the Price/Earnings ratio of CRBP2 indicates a rather cheap valuation: CRBP2 is cheaper than 93.52% of the companies listed in the same industry.

When comparing the Price/Earnings ratio of CRBP2 to the average of the S&P500 Index (26.46), we can say CRBP2 is valued rather cheaply.

		Industry Rank	Sector Rank
PE	7.02
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)3.56

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

CRBP2 has a Yearly Dividend Yield of 3.94%. Purely for dividend investing, there may be better candidates out there.

Compared to an average industry Dividend Yield of 4.69, CRBP2 has a dividend in line with its industry peers.

CRBP2's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.

		Industry Rank	Sector Rank
Dividend Yield	3.94%

5.2 History

The dividend of CRBP2 has a limited annual growth rate of 1.20%.

Dividend Growth(5Y)1.2%

Div Incr Years3

Div Non Decr Years3

5.3 Sustainability

The dividend of CRBP2 is growing, but earnings are growing more, so the dividend growth is sustainable.

DPN/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CRCAM BRIE PIC2-CCI

EPA:CRBP2 (12/5/2025, 7:00:00 PM)

28.23

+0.55 (+2.01%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupBanks

GICS IndustryBanks

Earnings (Last)10-28 2025-10-28

Earnings (Next)01-28 2026-01-28

Inst Owners3.52%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap451.96M

Revenue(TTM)837.21M

Net Income(TTM)218.51M

Analysts83.64

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	3.94%

Yearly Dividend0.71

Dividend Growth(5Y)1.2%

DPN/A

Div Incr Years3

Div Non Decr Years3

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	7.02
Fwd PE	N/A
P/S	0.54
P/FCF	N/A
P/OCF	N/A
P/B	0.08
P/tB	0.08
EV/EBITDA	N/A

EPS(TTM)4.02

EY14.24%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-27.7

FCFYN/A

OCF(TTM)-26.94

OCFYN/A

SpS52.29

BVpS353.77

TBVpS353.75

PEG (NY)N/A

PEG (5Y)3.56

Graham Number178.88

Profitability

		Industry Rank	Sector Rank
ROA	0.53%
ROE	3.86%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	26.1%
GM	N/A
FCFM	N/A

ROA(3y)0.47%

ROA(5y)0.46%

ROE(3y)3.92%

ROE(5y)3.92%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-6.32%

PM growth 5Y-2.49%

GM growth 3YN/A

GM growth 5YN/A

F-Score5

Asset Turnover0.02

Health

		Industry Rank	Sector Rank
Debt/Equity	0.2
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	59.41%
Cap/Sales	1.46%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	N/A
Quick Ratio	N/A
Altman-Z	N/A

F-Score5

WACC6.12%

ROIC/WACCN/A

Cap/Depr(3y)66.63%

Cap/Depr(5y)90.89%

Cap/Sales(3y)1.62%

Cap/Sales(5y)2.37%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)7.82%

EPS 3Y-3.01%

EPS 5Y1.97%

EPS Q2Q%14.31%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-1.48%

Revenue growth 3Y3.81%

Revenue growth 5Y4.72%

Sales Q2Q%-1.45%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1YN/A

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y81.89%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y82.29%

OCF growth 3YN/A

OCF growth 5YN/A

CRCAM BRIE PIC2-CCI / CRBP2.PA FAQ

What is the ChartMill fundamental rating of CRCAM BRIE PIC2-CCI (CRBP2.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CRBP2.PA.

Can you provide the valuation status for CRCAM BRIE PIC2-CCI?

ChartMill assigns a valuation rating of 2 / 10 to CRCAM BRIE PIC2-CCI (CRBP2.PA). This can be considered as Overvalued.

What is the profitability of CRBP2 stock?

CRCAM BRIE PIC2-CCI (CRBP2.PA) has a profitability rating of 2 / 10.

What are the PE and PB ratios of CRCAM BRIE PIC2-CCI (CRBP2.PA) stock?

The Price/Earnings (PE) ratio for CRCAM BRIE PIC2-CCI (CRBP2.PA) is 7.02 and the Price/Book (PB) ratio is 0.08.

How financially healthy is CRCAM BRIE PIC2-CCI?

The financial health rating of CRCAM BRIE PIC2-CCI (CRBP2.PA) is 2 / 10.

CRCAM BRIE PIC2-CCI (CRBP2.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens

CRCAM BRIE PIC2-CCI / CRBP2.PA FAQ

What is the ChartMill fundamental rating of CRCAM BRIE PIC2-CCI (CRBP2.PA) stock?

Can you provide the valuation status for CRCAM BRIE PIC2-CCI?

What is the profitability of CRBP2 stock?

What are the PE and PB ratios of CRCAM BRIE PIC2-CCI (CRBP2.PA) stock?

How financially healthy is CRCAM BRIE PIC2-CCI?